Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 38925293
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison.
Diabetes research and clinical practice
2024
1 citation
PMID: 38925293
View on PubMed
DOI: 10.1016/j.diabres.2024.111759
Semaglutide
Tirzepatide
Authors
Zaheer, Hamza; Hammad Zaheer, Muhammad
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison. | Pepdox